Pregabalin

• The Effect of Nonsteroidal Anti-Inflammatory Drug Contraindications on Opioid Use, Length of Stay, and Patient-Reported Outcomes After Lumbar Fusion
• Rare case of schwannomatosis presenting with cauda equina syndrome: a case report
• The 2016 CDC Opioid Guideline and Analgesic Prescribing Patterns in Older Adults With Cancer
• Oral cannabinoid formulation elevates sensory nerve conduction velocity and mitigates oxidative stress to alleviate neuropathic pain in rats
• Gabapentinoids and Hip Fracture: A Pharmacovigilance Comparative Study Between Gabapentin and Pregabalin
• The Lethal Combination of Pregabalin With Other Recreational Drugs
• Harms associated with prescription drug misuse in Ireland: A national observational study of trends in treatment demand, non-fatal intentional drug overdoses and drug related deaths 2010-2020
• Crisugabalin, a ligand for the α₂δ subunit of voltage-gated calcium channels, exhibits no obvious abuse potential in rodents

Pregabalin is a medication that belongs to the class of drugs known as gabapentinoids. It is commonly prescribed to treat various conditions, primarily neuropathic pain, and also as an anticonvulsant. Here are some key points about pregabalin:

Pregabalin works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. By binding to these channels, pregabalin modulates the release of neurotransmitters, including glutamate, reducing the excitability of nerve cells.

Pregabalin for Partial seizure

Pregabalin for Neuropathic Pain

Fibromyalgia: It is also approved for the treatment of fibromyalgia, a chronic pain disorder.

The dosage of pregabalin varies depending on the specific condition being treated. It is usually taken orally in the form of capsules or tablets, with or without food.

Extended-release pregabalin is a formulation designed for once-daily administration, offering greater convenience and adherence to treatment. It is primarily indicated for the following conditions:

Neuropathic pain: associated with diabetic neuropathy, postherpetic neuralgia, or central neuropathic pain. Epilepsy: as an adjunctive therapy for partial-onset seizures, with or without secondary generalization. Generalized Anxiety Disorder (GAD): in adults. Characteristics of the Extended-Release Formulation: Advantages:

Maintains stable plasma levels over a longer period. Reduces peaks and troughs in plasma concentration, potentially minimizing side effects. Improves treatment adherence due to less frequent dosing. Pharmacokinetics:

Absorption is slower compared to the immediate-release formulation, allowing for once-daily dosing. Recommended to be taken with food to optimize absorption. Dosage Adjustments: As with immediate-release pregabalin, doses should be adjusted based on clinical response and patient tolerance, with special consideration for: Patients with renal impairment: dosage adjustments based on creatinine clearance. Discontinuation: should be tapered off gradually to prevent withdrawal symptoms. Comparison with Immediate-Release Pregabalin: The efficacy profile is similar, but the extended-release version may provide improved convenience for certain patients.

Common side effects may include dizziness, drowsiness, weight gain, and blurred vision. Some people may experience more serious side effects, such as allergic reactions or changes in mood or behavior.

Pregabalin may interact with certain medications, so it's important to inform your healthcare provider about all the drugs you are taking. It should be used with caution in individuals with a history of drug or alcohol abuse.

Abruptly stopping pregabalin can lead to withdrawal symptoms, so it is usually tapered off under the guidance of a healthcare professional. There is a potential for abuse and dependence, so it should be used with caution in individuals with a history of substance abuse.

Pregabalin is a prescription medication, and its use should be supervised by a healthcare professional who can assess the individual's health status and tailor the treatment plan accordingly. It's important to note that the information provided here is a general overview, and specific details about the use of pregabalin should be discussed with a healthcare provider based on an individual's medical history and condition.